RECOMBIVAX HB
RECOMBIVAX HB
Approved
DIN Number
02243676
Drug Class
Human
Market Date
Apr 11, 2001
Company
HC
Merck Canada Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02243676
AIG Number0119570001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BC01 HEPATITIS B, PURIFIED ANTIGEN
Product Specifications
Dosage FormSuspension
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)Active
Strength: 10 MCG / ML
Monograph: HEPATITIS B SURFACE ANTIGEN (RECOMBINANT)